BeStock  
Markets › Compare › ACAD vs LIF

ACAD vs LIF

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ACAD · ACADIA Pharmaceuticals$20.11 ▲ 0.80%
LIF · Life360$42.57 ▼ 1.23%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

305989119148Oct 7, '25Apr 7, '26Oct 5, '26
  • ACAD -6.6%
  • LIF -59.9%

Head to head

MetricACADLIF
Price$20.11$42.57
Change today▲ 0.80%▼ 1.23%
Market cap$3.47B$3.47B
Return, 3 months-23.2%-24.4%
Return, year to date-24.7%-33.6%
Return, 1 year-6.9%-61.6%
P/E (TTM)9.024.8
P/B2.75.7
P/E percentile vs own 5y57th50th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+68.3%+44.6%
Analyst buy share85%83%
RSI (14)1850
30-day volatility49.2%39.2%
Max drawdown, 1 year-34.9%-65.6%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LIF is the largest of the group by market value.
  • ACAD has returned the most over the past year.
  • ACAD carries the lowest trailing P/E.
  • LIF has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top